Communication During Hospitalization About Resuscitation Trial

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 182 participants.

Also called NCT02984124

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose other
Phase
Phase 2/3
Enrolled
  • 182 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02984124
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02984124. Randomized; no masking; primary purpose other. Start 2016-12 (actual); primary completion 2023-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Communication During Hospitalization About Resuscitation Trial
Acronym
CHART
Condition
Severe Life-limiting COPD
Condition
Severe Life-limiting Heart Failure
Condition
Severe Life-limiting Cirrhosis
Condition
Severe Life-limiting Malignancy
Condition
Severe Functional Impairment
Condition
End Stage Renal Disease
Intervention (Behavioral)
Informed Assent Discussion
Intervention (Behavioral)
Usual Care with Attention Control
Lead sponsor
University of Vermont (class: other)
Collaborator
University of Washington (class: other)
Collaborator
Medical University of South Carolina (class: other)
Collaborator
University of North Carolina, Chapel Hill (class: other)

Record details

Record id
cardio:ct-nct02984124
Content hash
9ab149dbe15ef73679fe55717afc969f7ec0201781381856beae6a8a808267d5